Rearming the body’s immune system to fight cancer

We’re developing more precise and more accessible treatment alternatives for patients with solid cancers

Pioneering excellence in the field of immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.

Learn more about us

Some of our partners

Latest news

Happy 80th to Cartherics Scientific Advisor Irv Weissman

By Karen Loudon / October 14, 2019
For more information click the link here ..... Cartherics CEO Alan Trounson to attend Irv Weissman's 80th Birthday Celebration Symposium...
Read More

The Good Fight

By Karen Loudon / September 19, 2019
ABC - Australian Story ..... When Newcastle radio host Jill Emberson was told she had terminal ovarian cancer, she opted...
Read More

How ToolGen met Cartherics

By Karen Loudon / September 16, 2019
To borrow from Louis Pasteur, ‘collaboration’ favours the prepared mind … and networking helps, as ToolGen’s Jae Young Lee well...
Read More